The International Society for Cell and Gene Therapy (ISCT), the global professional society of clinicians, researchers, regulatory specialists, technologists and industry partners in the cell and gene therapy sector, announced the first publication of its new annual report detailing global cell and gene therapies (CGT) with market authorization.
CGTs are progressively entering into clinical practice in different parts of the world. Considering the number of products that have been progressively approved and, in some cases, withdrawn in recent years, the ISCT wanted to present a brief annual report on CGTs with marketing authorization in different regions
The CGT market authorization report is intended to provide a centralized resource and increased clarity for all of those involved in the CGT industry. This involves the scientific community, healthcare stakeholders and patient associations. The report will be a regularly updated document that will be republished yearly, and accessible through the ISCT website.
Read the report here
Read about the dangers of unproven stem cell therapy clinics here
[javascriptSnippet]
